Results for Kidney Disease

1 - 10 of 145

Dr. Guay-Woodford is an internationally recognized pediatric nephrologist with a research program focused on identifying clinical and genetic factors involved in the pathogenesis of inherited renal disorders, most notably autosomal recessive polycystic kidney disease.

E-mail:

guaywoodfl [at] chop.edu

Erum A. Hartung, MD, MTR

Dr. Hartung's clinical and translational research program focuses on autosomal recessive polycystic kidney disease and other genetic kidney diseases, development of new kidney and liver imaging biomarkers, and neurocognitive outcomes in children with chronic kidney disease.

E-mail:

hartunge [at] chop.edu

Jarcy Zee, PhD

Dr. Zee's statistical methods research includes topics in survival analysis, measurement error, observational data methods, and machine learning. Her clinical research is focused on kidney disease, specifically in clinical and pathology markers of glomerular and chronic kidney disease progression.

E-mail:

zeej [at] chop.edu

Gregory Tasian, MD, MSCE

Dr. Tasian and his research team use an epidemiologic framework, including randomized trials and multi-institutional observational studies, to examine the etiology of kidney stone disease and the comparative effectiveness of surgical interventions. He also employs machine learning of complex data to improve diagnosis, risk stratification, and prediction of treatment response for children and adults with benign urologic disease.

E-mail:

tasiang [at] chop.edu

Michelle Denburg, MD, MSCE

Dr. Denburg addresses fundamental limitations in understanding of skeletal morbidity in patients with chronic kidney disease, glomerular disease, and urinary stone disease, and develops resources to conduct observational research and trials to optimize health outcomes in these high risk populations.

E-mail:

denburgm [at] chop.edu

Benjamin L. Laskin, MD, MS

Dr. Laskin's research focuses on the conduct of clinical investigations and translational studies designed to target mechanisms to prevent, treat, or slow the progression of chronic kidney disease in immunosuppressed patients, including children receiving a bone marrow or kidney transplant.

E-mail:

laskinb [at] chop.edu

Susan L. Furth, MD, PhD

Dr. Furth's research focuses on defining risk factors for kidney disease progression in children; characterizing the effect of kidney function decline on neurodevelopment, cognitive abilities and behavior; identifying the prevalence and evolution of cardiovascular disease risk factors, and examining the effects of declining glomerular filtration rate on children’s growth.

E-mail:

furths [at] chop.edu

Christopher LaRosa, MD

Dr. LaRosa's research interests include renal transplantation, nephrolithiasis/kidney stones, glomerular diseases, and pediatric hypertension.

E-mail:

larosac [at] chop.edu

Daniella Levy-Erez, MD

Dr. Levy-Erez's research is focused on the discovery of immune urinary biomarkers among children developing acute kidney injury. She is studying both a unique population of immune-compromised children after hematopoietic stem cell transplantation (HSCT) as well as children who have an intact immune system who develop acute kidney injury after cardiac bypass surgery.

E-mail:

levyerezd [at] chop.edu

Madhura Pradhan, MD, MBBS

Dr. Pradhan is chief of the Division of Nephrology and outpatient director of the Dialysis Unit at Children's Hospital of Philadelphia, and professor of Clinical Pediatrics in the Perelman School of Medicine at the University of Pennsylvania. Her research focuses on neuroimaging in chronic kidney disease.

E-mail:

pradhan [at] chop.edu